Prevalence of metabolic syndrome in the workplace: case of a Senegalese company

Introduction
The aim of this study is to assess the frequency of this pathology based on definitions established by WHO and the NCEP-ATPIII in a Senegalese population, search relationship and cardiovascular risk factors. 

Methods
902 workers aged 20 to 60 years are concern and received wide review: general examination, cardiopulmonary examination: ECG, possibly cardiac ultrasound and x-ray, complete blood count . Anthropometric, clinical and biological parameters involved in the development of the syndrome, were studied. 

Results
clinically: 28.05% hypertension, obesity: 11.75 BMI 31.04 WC 39.91 WC/HC 
Biological: Hyperglycemia: 10.09, 4.77 IFG, 5.32 diabetes. , Dyslipidemia: hypertriglyceridemia, 21.84, 38.25 HDLcholestérol low, High LDLcholestérol: 25.06 
Positive Correlation: glucose and blood pressure, triglycerides and DBP, triglycerides and BMI, LDL-cholesterol and SBP, 
Negatively correlated HDL-cholesterol and blood pressure, HDL cholesterol and BMI. 

Discussion
• Incidence of metabolic syndrome as defined by 
• WHO: 8.87. This frequency is low compared to that observed in the U.S. and European populations: respectively 41.3 and 23. High prevalence observed in the US and Europe could be explained by their lifestyle, including diet and physical inactivity. 
• NCEP-ATPIII: 22.73. This frequency is remarkable because indicates that the syndrome is almost one-fifth of subjects is similar to that told in a U.S 21.8 using the same criteria. 
• Comparison of frequencies found by WHO and NCEP-ATPIII: 
NCEP-ATPIII‘s frequency is 2.6 times higher than WHO. It follows that WHO criteria would be less sensitive for the detection of metabolic syndrome than NCEP-ATPIII. Therefore it’s more likely to diagnose the syndrome by applying NCEP-ATPIII definition than WHO’s. Indeed.